Hirotomo Dochi
8PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 20, 2026
Expression of Glycoprotein B (gB) Correlates With Poor Prognosis in Nasopharyngeal Carcinoma.Shigetaka Komura, Satoru Kondo, Hideya Kawasaki
|Apr 17, 2025
Increased Expression of Superoxide Dismutase 2 Is an Indicator of Worse Prognosis of Oropharyngeal Cancer.Yoshitaka Aoki, Satoru Kondo, Eiji Kobayashi
|Aug 28, 2024
Phosphoribosyl pyrophosphate amidotransferase: Novel biomarker and therapeutic target for nasopharyngeal carcinoma.Yuki Kitagawa, Satoru Kondo, Masaki Fukuyo
|Jan 26, 2024
Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma.Tomokazu Yoshizaki, Satoru Kondo, Hirotomo Dochi
|Nov 01, 2023
Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker.Hirotomo Dochi, Satoru Kondo, Shigetaka Komura
|May 28, 2022
Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma.Hirotomo Dochi, Satoru Kondo, Takayuki Murata
Pageof 2
Frequent Collaborators
5 joint publications
Satoru Kondo
4 joint publications
Atsushi Kaneda
3 joint publications
Tomokazu Yoshizaki
2 joint publications
Kousho Wakae
2 joint publications
Eiji Kobayashi
2 joint publications
Yuki Kitagawa
1 joint publications
Hiroshi Kimura
1 joint publications
Asuka Nanbo
1 joint publications
Toshihide Hamabe-Horiike
1 joint publications
Makiko Moriyama-Kita
